Artificial pancreas uses adaptive algorithm to manage type-2 diabetes

In 2016, the US Food and Drug Administration (FDA) issued its first approval of an “artificial pancreas” for type-1 diabetes that automatically monitors blood sugar levels and doses the patient with the appropriate amount of insulin. In the latest evolution of this technology, the same type of system is now being tested in people who have type-2 diabetes. The University … Continue reading